DETAILED NOTES ON ABBV-744 BRD4 INHIBITOR MECHANISM OF ACTION

In Phase A, participants will acquire distinctive doses and schedules of oral ABBV-744 pill to recognize Safe and sound dosing routine. Extra participants will be enrolled for the recognized monotherapy dosign program. In Section B, participants will get oral ruxolitinib and ABBV-744 is going to be provided as "add-on" therapy. In Section C, member